Related Experiment Video

Updated: May 22, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells

Yu Wang1, Qiao Liu, Zhaojian Liu

  • 1Ministry of Education Key Laboratory of Experimental Teratology and Institute of Molecular Medicine and Genetics, Shandong University School of Medicine, Jinan, China.

Mutation Research
|May 8, 2012
PubMed

Insights

Berberine halts cancer cell growth by causing DNA damage and apoptosis. This study reveals berberine induces G2/M arrest via the ATM-Chk1 pathway, suggesting combination therapies for enhanced anti-cancer effects.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Berberine exhibits anti-tumor properties across various cancer types.
  • Berberine induces G1 arrest via p53-p21, but G2/M arrest mechanisms are unclear.
  • Prostate cancer remains a significant health concern, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the anti-proliferative effects of berberine on RM-1 murine prostate cancer cells.
  • To elucidate the molecular mechanisms underlying berberine-induced G2/M cell cycle arrest.
  • To explore potential combination therapies for enhanced cancer cell killing.

Main Methods:

  • Cell proliferation assays on RM-1 cells treated with berberine.
  • Analysis of DNA damage, apoptosis, and cell cycle progression.
  • Pharmacological inhibition and RNA interference targeting ATM and Chk1 pathways.

Main Results:

  • Berberine induced dose-dependent DNA double-strand breaks, apoptosis, and cell cycle arrest (G1 and G2/M).
  • Berberine-induced G2/M arrest is p53-independent and mediated by the ATM-Chk1 pathway.
  • Inhibition of ATM or Chk1 abrogated berberine-induced G2/M arrest, increasing apoptosis.

Conclusions:

  • Berberine effectively inhibits prostate cancer cell proliferation through DNA damage and apoptosis induction.
  • The ATM-Chk1 pathway is crucial for berberine-induced G2/M arrest.
  • Combined berberine with ATM inhibitors (e.g., caffeine) may enhance anti-cancer efficacy.

More Related Videos

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...